A Delaware court has approved a bankruptcy plan for Insys Therapeutics (OTCPK:INSYQ), the first company to file for Chapter 11 protection over opioid epidemic-related legal exposure.
Unsurprisingly, shareholders will be wiped out. Most creditors will only receive only about eight cents on the dollar.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.